Executive Summary

Since 2014, essential safeguards within the federal budget have protected state-authorized medical cannabis programs from federal encroachment. However, the proposed presidential budget for 2026 has notably omitted the crucial rider that has historically prohibited the United States Department of Justice from utilizing federal funds to prosecute medical cannabis patients and providers. This omission threatens to dismantle established protections, potentially subjecting patients, employees, and enterprises in all 39 jurisdictions with medical cannabis legislation to federal criminal prosecution. Given that the United States Congress possesses the definitive authority over the federal budget, it is imperative to launch a comprehensive advocacy initiative to ensure that these fundamental safeguards are reinstated and preserved.

Background and Context

• Established Protection: Since 2014, a critical provision has been consistently incorporated into the federal budget, serving to protect state-legal medical cannabis programs. This provision has effectively prevented federal law enforcement agencies, particularly the Department of Justice, from interfering with state medical cannabis laws and operations.
• Omission in 2026 Budgetary Proposal: The President’s budgetary proposal for 2026 represents a significant and concerning deviation from established precedent. The absence of the rider that restrains the Justice Department from prosecuting medical cannabis activities indicates a potential alteration in federal policy and poses an immediate risk to the integrity of state programs.
• Congressional Prerogative: It is of utmost importance to acknowledge that the authority to enact the federal budget resides with the United States Congress. This understanding forms the foundation of the advocacy strategy. Through engagement with members of Congress, advocates can influence the budgetary process and ensure the reinstatement of these vital protections.

Core Message

The principal message of this campaign is to earnestly request that the United States Congress maintain protections for medical cannabis patients in all 39 states that have legalized medical cannabis. This protection guarantees their access to necessary medication without the fear of federal prosecution and upholds the rights of states to govern their own healthcare regulations.

Potential Consequences of Inaction

• National Criminalization: The removal of the long-standing protection would engender an environment where federal prosecution of medical cannabis activities becomes a viable possibility. This could precipitate the apprehension and legal proceedings against patients, employees of legally operating cannabis businesses, and even proprietors of said businesses, irrespective of state legality.
• Vulnerable Patient Demographics: Medical cannabis patients, frequently individuals afflicted with chronic illnesses or disabilities, depend upon their medication for alleviation and therapeutic purposes. Federal interference would jeopardize their access to care and potentially criminalize their prescribed medical treatment.
• Erosion of State Sovereignty: Overturning the extant protection would undermine the sovereignty of individual states to legislate on healthcare matters within their respective jurisdictions. This would establish a precarious precedent for future federal overreach.

Call to Action

Constituents must actively engage with their respective legislators and urge them to reinstate and uphold the provisions that safeguard medical cannabis patients. Direct communication through telephonic contact, electronic mail, and formal correspondence is essential to conveying the gravity of this issue.

MAKE YOUR VOICE HEARD

Objective

The primary objective of this advocacy campaign is to ensure that the United States Congress affirms legal access to medical cannabis by reinserting the protective rider into the finalized federal budget. The overarching goal is to protect patients and the integrity of state medical cannabis programs.

Target Demographic

The campaign is principally directed towards members of the United States Congress, encompassing both Representatives and Senators. Specific committees and individuals who wield influence over budgetary decisions should be explicitly targeted.

Strategy

• Mobilization of Stakeholders: Galvanize medical cannabis patients, healthcare providers, advocacy organizations, and concerned citizens to contact their representatives.
• Formulation of Persuasive Communication: Develop clear and compelling messaging that accentuates the human ramifications of removing the protections.
• Presentation of Empirical Data and Evidence: Present statistical data and personal testimonies that illustrate the salutary effects of medical cannabis and the detrimental consequences of federal intervention.
• Engagement with Media Outlets: Cultivate media coverage to amplify the message and enhance public awareness.
• Strategic Collaboration: Forge alliances with national and state-level organizations to maximize outreach and impact.
• Implementation of Digital Campaign: Utilize social media platforms, electronic mail campaigns, and online petitions to garner support and facilitate communication with legislators.
• Direct Lobbying Initiatives: Arrange meetings with congressional offices to present arguments and concerns directly.